Taiwan · Delayed Price · Currency is TWD Lotus Pharmaceutical Statistics
Total Valuation
TPE:1795 has a market cap or net worth of TWD 51.25 billion. The enterprise value is 93.06 billion.
| Market Cap | 51.25B |
| Enterprise Value | 93.06B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Aug 11, 2025 |
Share Statistics
TPE:1795 has 262.81 million shares outstanding. The number of shares has decreased by -1.10% in one year.
| Current Share Class | 262.81M |
| Shares Outstanding | 262.81M |
| Shares Change (YoY) | -1.10% |
| Shares Change (QoQ) | +8.08% |
| Owned by Insiders (%) | 0.82% |
| Owned by Institutions (%) | 10.87% |
| Float | 133.40M |
Valuation Ratios
The trailing PE ratio is 13.20 and the forward PE ratio is 11.45.
| PE Ratio | 13.20 |
| Forward PE | 11.45 |
| PS Ratio | 2.10 |
| PB Ratio | 2.13 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.98 |
| P/OCF Ratio | 10.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.27, with an EV/FCF ratio of 27.20.
| EV / Earnings | 24.16 |
| EV / Sales | 3.81 |
| EV / EBITDA | 11.27 |
| EV / EBIT | 14.42 |
| EV / FCF | 27.20 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 2.00.
| Current Ratio | 1.59 |
| Quick Ratio | 0.95 |
| Debt / Equity | 2.00 |
| Debt / EBITDA | 5.81 |
| Debt / FCF | 14.03 |
| Interest Coverage | 3.31 |
Financial Efficiency
Return on equity (ROE) is 17.03% and return on invested capital (ROIC) is 8.17%.
| Return on Equity (ROE) | 17.03% |
| Return on Assets (ROA) | 5.44% |
| Return on Invested Capital (ROIC) | 8.17% |
| Return on Capital Employed (ROCE) | 7.07% |
| Weighted Average Cost of Capital (WACC) | 5.19% |
| Revenue Per Employee | 22.22M |
| Profits Per Employee | 3.50M |
| Employee Count | 1,099 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.69 |
Taxes
In the past 12 months, TPE:1795 has paid 849.87 million in taxes.
| Income Tax | 849.87M |
| Effective Tax Rate | 18.08% |
Stock Price Statistics
The stock price has decreased by -16.84% in the last 52 weeks. The beta is 0.49, so TPE:1795's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -16.84% |
| 50-Day Moving Average | 214.94 |
| 200-Day Moving Average | 253.69 |
| Relative Strength Index (RSI) | 39.68 |
| Average Volume (20 Days) | 3,455,156 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1795 had revenue of TWD 24.42 billion and earned 3.85 billion in profits. Earnings per share was 14.77.
| Revenue | 24.42B |
| Gross Profit | 13.38B |
| Operating Income | 6.45B |
| Pretax Income | 4.70B |
| Net Income | 3.85B |
| EBITDA | 8.13B |
| EBIT | 6.45B |
| Earnings Per Share (EPS) | 14.77 |
Balance Sheet
The company has 6.20 billion in cash and 48.00 billion in debt, with a net cash position of -41.81 billion or -159.08 per share.
| Cash & Cash Equivalents | 6.20B |
| Total Debt | 48.00B |
| Net Cash | -41.81B |
| Net Cash Per Share | -159.08 |
| Equity (Book Value) | 24.03B |
| Book Value Per Share | 84.74 |
| Working Capital | 9.66B |
Cash Flow
In the last 12 months, operating cash flow was 4.73 billion and capital expenditures -1.31 billion, giving a free cash flow of 3.42 billion.
| Operating Cash Flow | 4.73B |
| Capital Expenditures | -1.31B |
| Depreciation & Amortization | 1.68B |
| Net Borrowing | 10.16B |
| Free Cash Flow | 3.42B |
| FCF Per Share | 13.02 |
Margins
Gross margin is 54.77%, with operating and profit margins of 26.41% and 15.77%.
| Gross Margin | 54.77% |
| Operating Margin | 26.41% |
| Pretax Margin | 19.25% |
| Profit Margin | 15.77% |
| EBITDA Margin | 33.30% |
| EBIT Margin | 26.41% |
| FCF Margin | 14.01% |
Dividends & Yields
This stock pays an annual dividend of 2.56, which amounts to a dividend yield of 1.31%.
| Dividend Per Share | 2.56 |
| Dividend Yield | 1.31% |
| Dividend Growth (YoY) | 24.34% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 39.45% |
| Buyback Yield | 1.10% |
| Shareholder Yield | 2.45% |
| Earnings Yield | 7.52% |
| FCF Yield | 6.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPE:1795 has an Altman Z-Score of 1.21 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 4 |